Class Action & Mass Torts

Email Updates Blogs RSS Link
Have you heard about the Dallas-based company selling limited partnership interests in an investment that returns 12%/annually, paid twice a year? The company claims to have 10,000 investors who have invested $250 million and earned $30 million interest. Sounds great. Right? Not so fast! Prestige Equity is yet another investment scam, like thousands before it. Recently, the Texas State Securities Board issued a cease and desist order to Robert Clemmons, Felix Crayborn, Grant Myers, William…
Ballard v. NTB Financial Corporation was filed in the Arapahoe County District Court on July 7, 2021, claiming that Defendants conspired with Financial Visions, Inc. (“FV”) and its principal, Dan Rudden (“Rudden”), to induce investors into purchasing unregistered securities in violation of antifraud provisions of the Colorado Securities Act. Plaintiffs are individuals and a business entity who invested in promissory notes sold by FV and Rudden. Defendants are NTB Financial Corporation (“NTB”), an investment firm…
Increased Risk for This New Vision/Eyes Side Effect Highest in Elderly Patients and Chronic Kidney Disease Patients   (Posted by Tom Lamb at Drug Injury Watch)   In June 2021 it was reported that Invokana, Farxiga, and Jardiance, as well as other drugs in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors class, are associated with an increased risk of retinal vein occlusion. This new SGLT2 inhibitors side effect was the subject of a presentation at the…